Distribution of the Hexanucleotide Repeat Expansion in Healthy Subjects: a Multicenter Study Promoted by the Italian IRCCS Network of Neuroscience and Neurorehabilitation

Introduction: High repeat expansion (HRE) alleles in have been linked to both amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD); ranges for intermediate allelic expansions have not been defined yet, and clinical interpretation of molecular data lacks a defined genotype-phenotype association. In this study, we provide results from a large multicenter epidemiological study reporting the distribution of repeats in healthy elderly from the Italian population.

Methods: A total of 967 samples were collected from neurologically evaluated healthy individuals over 70 years of age in the 13 institutes participating in the RIN (IRCCS Network of Neuroscience and Neurorehabilitation) based in Italy. All samples were genotyped using the AmplideXPCR/CE Kit (Asuragen, Inc.), using standardized protocols that have been validated through blind proficiency testing.

Results: All samples carried hexanucleotide GC expansion alleles in the normal range. All samples were characterized by alleles with less than 25 repeats. In particular, 93.7% of samples showed a number of repeats ≤10, 99.9% ≤20 repeats, and 100% ≤25 repeats.

Conclusion: This study describes the distribution of hexanucleotide GC expansion alleles in an Italian healthy population, providing a definition of alleles associated with the neurological healthy phenotype. Moreover, this study provides an effective model of federation between institutes, highlighting the importance of sharing genomic data and standardizing analysis techniques, promoting translational research. Data derived from the study may improve genetic counseling and future studies on ALS/FTD.

Citing Articles

AI-Powered Neurogenetics: Supporting Patient's Evaluation with Chatbot.

Zampatti S, Farro J, Peconi C, Cascella R, Strafella C, Calvino G Genes (Basel). 2025; 16(1).

PMID: 39858576 PMC: 11765031. DOI: 10.3390/genes16010029.

Federated Learning: Breaking Down Barriers in Global Genomic Research.

Calvino G, Peconi C, Strafella C, Trastulli G, Megalizzi D, Andreucci S Genes (Basel). 2025; 15(12.

PMID: 39766917 PMC: 11728131. DOI: 10.3390/genes15121650.

Deciphering the Complexity of FSHD: A Multimodal Approach as a Model for Rare Disorders.

Megalizzi D, Trastulli G, Colantoni L, Proietti Piorgo E, Primiano G, Sancricca C Int J Mol Sci. 2024; 25(20).

PMID: 39456731 PMC: 11507453. DOI: 10.3390/ijms252010949.

Mutational Landscape of Alzheimer's Disease and Frontotemporal Dementia: Regional Variances in Northern, Central, and Southern Italy.

Saraceno C, Pagano L, Lagana V, Geviti A, Bagnoli S, Ingannato A Int J Mol Sci. 2024; 25(13).

PMID: 39000146 PMC: 11241147. DOI: 10.3390/ijms25137035.

References

Hostettler I, Bernal-Quiros M, Wong A, Sharma N, Wilson D, Seiffge D . C9orf72 and intracerebral hemorrhage. Neurobiol Aging. 2019; 84:237.e1-237.e3. DOI: 10.1016/j.neurobiolaging.2019.07.007. View

Kaivola K, Kiviharju A, Jansson L, Rantalainen V, Eriksson J, Strandberg T . C9orf72 hexanucleotide repeat length in older population: normal variation and effects on cognition. Neurobiol Aging. 2019; 84:242.e7-242.e12. PMC: 8981799. DOI: 10.1016/j.neurobiolaging.2019.02.026. View

Iacoangeli A, Al Khleifat A, Jones A, Sproviero W, Shatunov A, Opie-Martin S . C9orf72 intermediate expansions of 24-30 repeats are associated with ALS. Acta Neuropathol Commun. 2019; 7(1):115. PMC: 6637621. DOI: 10.1186/s40478-019-0724-4. View

Al Khleifat A, Iacoangeli A, van Vugt J, Bowles H, Moisse M, Zwamborn R . Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis. NPJ Genom Med. 2022; 7(1):8. PMC: 8799638. DOI: 10.1038/s41525-021-00267-9. View

Gijselinck I, Van Mossevelde S, van der Zee J, Sieben A, Engelborghs S, De Bleecker J . The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter. Mol Psychiatry. 2015; 21(8):1112-24. PMC: 4960451. DOI: 10.1038/mp.2015.159. View

Rutherford N, Heckman M, DeJesus-Hernandez M, Baker M, Soto-Ortolaza A, Rayaprolu S . Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype. Neurobiol Aging. 2012; 33(12):2950.e5-7. PMC: 3617405. DOI: 10.1016/j.neurobiolaging.2012.07.005. View

Riggs J . Longitudinal Gompertzian analysis of amyotrophic lateral sclerosis mortality in the U.S., 1977-1986: evidence for an inherently susceptible population subset. Mech Ageing Dev. 1990; 55(3):207-20. DOI: 10.1016/0047-6374(90)90149-a. View

Vance C, Al-Chalabi A, Ruddy D, Smith B, Hu X, Sreedharan J . Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3. Brain. 2006; 129(Pt 4):868-76. DOI: 10.1093/brain/awl030. View

Breevoort S, Gibson S, Figueroa K, Bromberg M, Pulst S . Expanding Clinical Spectrum of -Related Disorders and Promising Therapeutic Strategies: A Review. Neurol Genet. 2022; 8(3):e670. PMC: 9128039. DOI: 10.1212/NXG.0000000000000670. View

10.

Nordin A, Akimoto C, Wuolikainen A, Alstermark H, Forsberg K, Baumann P . Sequence variations in C9orf72 downstream of the hexanucleotide repeat region and its effect on repeat-primed PCR interpretation: a large multinational screening study. Amyotroph Lateral Scler Frontotemporal Degener. 2016; 18(3-4):256-264. DOI: 10.1080/21678421.2016.1262423. View

11.

Xi Z, Zinman L, Grinberg Y, Moreno D, Sato C, Bilbao J . Investigation of c9orf72 in 4 neurodegenerative disorders. Arch Neurol. 2012; 69(12):1583-90. PMC: 4005900. DOI: 10.1001/archneurol.2012.2016. View

12.

Moore K, Nicholas J, Grossman M, McMillan C, Irwin D, Massimo L . Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. Lancet Neurol. 2019; 19(2):145-156. PMC: 7007771. DOI: 10.1016/S1474-4422(19)30394-1. View

13.

de Boer S, Woolley L, Mol M, Serpente M, Reus L, van Minkelen R . Letter to the editor on a paper by Kaivola et al. (2020): carriership of two copies of C9orf72 hexanucleotide repeat intermediate-length alleles is not associated with amyotrophic lateral sclerosis or frontotemporal dementia. Acta Neuropathol Commun. 2022; 10(1):141. PMC: 9494883. DOI: 10.1186/s40478-022-01438-0. View

14.

Goldstein O, Gana-Weisz M, Nefussy B, Vainer B, Nayshool O, Bar-Shira A . High frequency of C9orf72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis patients from two founder populations sharing the same risk haplotype. Neurobiol Aging. 2018; 64:160.e1-160.e7. PMC: 5931221. DOI: 10.1016/j.neurobiolaging.2017.12.015. View

15.

Renton A, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs J . A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011; 72(2):257-68. PMC: 3200438. DOI: 10.1016/j.neuron.2011.09.010. View

16.

Roggenbuck J, Fong J . Genetic Testing for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: Impact on Clinical Management. Clin Lab Med. 2020; 40(3):271-287. DOI: 10.1016/j.cll.2020.05.002. View

17.

Jackson J, Finch N, Baker M, Kachergus J, DeJesus-Hernandez M, Pereira K . Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers. Mol Neurodegener. 2020; 15(1):7. PMC: 6993399. DOI: 10.1186/s13024-020-0359-8. View

18.

Roggenbuck J, Eubank B, Wright J, Harms M, Kolb S . Evidence-based consensus guidelines for ALS genetic testing and counseling. Ann Clin Transl Neurol. 2023; 10(11):2074-2091. PMC: 10646996. DOI: 10.1002/acn3.51895. View

19.

Fahey C, Byrne S, McLaughlin R, Kenna K, Shatunov A, Donohoe G . Analysis of the hexanucleotide repeat expansion and founder haplotype at C9ORF72 in an Irish psychosis case-control sample. Neurobiol Aging. 2014; 35(6):1510.e1-5. DOI: 10.1016/j.neurobiolaging.2013.12.003. View

20.

Bram E, Javanmardi K, Nicholson K, Culp K, Thibert J, Kemppainen J . Comprehensive genotyping of the C9orf72 hexanucleotide repeat region in 2095 ALS samples from the NINDS collection using a two-mode, long-read PCR assay. Amyotroph Lateral Scler Frontotemporal Degener. 2018; 20(1-2):107-114. PMC: 6513680. DOI: 10.1080/21678421.2018.1522353. View